Post-Transcriptional Control of Mirna Biogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Distinct E-Cadherin-Based Complexes Regulate Cell Behaviour Through Mirna Processing Or Src and P120 Catenin Activity
ARTICLES Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity Antonis Kourtidis1, Siu P. Ngok1,5, Pamela Pulimeno2,5, Ryan W. Feathers1, Lomeli R. Carpio1, Tiffany R. Baker1, Jennifer M. Carr1, Irene K. Yan1, Sahra Borges1, Edith A. Perez3, Peter Storz1, John A. Copland1, Tushar Patel1, E. Aubrey Thompson1, Sandra Citi4 and Panos Z. Anastasiadis1,6 E-cadherin and p120 catenin (p120) are essential for epithelial homeostasis, but can also exert pro-tumorigenic activities. Here, we resolve this apparent paradox by identifying two spatially and functionally distinct junctional complexes in non-transformed polarized epithelial cells: one growth suppressing at the apical zonula adherens (ZA), defined by the p120 partner PLEKHA7 and a non-nuclear subset of the core microprocessor components DROSHA and DGCR8, and one growth promoting at basolateral areas of cell–cell contact containing tyrosine-phosphorylated p120 and active Src. Recruitment of DROSHA and DGCR8 to the ZA is PLEKHA7 dependent. The PLEKHA7–microprocessor complex co-precipitates with primary microRNAs (pri-miRNAs) and possesses pri-miRNA processing activity. PLEKHA7 regulates the levels of select miRNAs, in particular processing of miR-30b, to suppress expression of cell transforming markers promoted by the basolateral complex, including SNAI1, MYC and CCND1. Our work identifies a mechanism through which adhesion complexes regulate cellular behaviour and reveals their surprising association with the microprocessor. p120 catenin (p120) was identified as a tyrosine phosphorylation with this, E-cadherin is still expressed in several types of aggressive substrate of the Src oncogene1 and an essential component of the and metastatic cancer18–20. -
The Oncogenic Role of Mir-155 in Breast Cancer
Published OnlineFirst June 26, 2012; DOI: 10.1158/1055-9965.EPI-12-0173 Cancer Epidemiology, MiniReview Biomarkers & Prevention The Oncogenic Role of miR-155 in Breast Cancer Sam Mattiske, Rachel J. Suetani, Paul M. Neilsen, and David F. Callen Abstract miR-155isanoncogenicmiRNAwithwelldescribedrolesinleukemia.However,additionalrolesof miR-155 in breast cancer progression have recently been described. A thorough literature search was conducted to review all published data to date, examining the role of miR-155 in breast cancer. Data on all validated miR-155 target genes was collated to identify biologic pathways relevant to miR-155 and breast cancer progression. Publications describing the clinical relevance, functional characterization, and regu- lation of expression of miR-155 in the context of breast cancer are reviewed. A total of 147 validated miR- 155 target genes were identified from the literature. Pathway analysis of these genes identified likely roles in apoptosis, differentiation, angiogenesis, proliferation, and epithelial–mesenchymal transition. The large number of validated miR-155 targets presented here provide many avenues of interest as to the clinical potential of miR-155. Further investigation of these target genes will be required to elucidate the specific mechanisms and functions of miR-155 in breast cancer. This is the first review examining the role of miR- 155 in breast cancer progression. The collated data of target genes and biologic pathways of miR-155 identified in this review suggest new avenues of research for this oncogenic miRNA. Cancer Epidemiol Biomarkers Prev; 21(8); 1236–43. Ó2012 AACR. Introduction found to regulate levels of LIN-14 protein (7, 8). Since this miRNAs are small noncoding RNAs that control discovery, there have been over 500 miRNAs described, expression of target genes by either inhibiting protein regulating a wide range of genes and cellular processes, translation or directly targeting mRNA transcripts of although the total predicted number of unique miRNAs target genes for degradation (1). -
Arsenic Trioxide-Mediated Suppression of Mir-182-5P Is Associated with Potent Anti-Oxidant Effects Through Up-Regulation of SESN2
www.impactjournals.com/oncotarget/www.oncotarget.com Oncotarget, 2018,Oncotarget, Vol. 9, (No.Advance 22), Publicationspp: 16028-16042 2018 Research Paper Arsenic trioxide-mediated suppression of miR-182-5p is associated with potent anti-oxidant effects through up-regulation of SESN2 Liang-Ting Lin1,10,*, Shin-Yi Liu2,*, Jyh-Der Leu3,4,*, Chun-Yuan Chang1, Shih-Hwa Chiou5,6,7, Te-Chang Lee7,8 and Yi-Jang Lee1,9 1Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan 2Department of Radiation Oncology, MacKay Memorial Hospital, Taipei, Taiwan 3Division of Radiation Oncology, Taipei City Hospital Ren Ai Branch, Taipei, Taiwan 4Institute of Neuroscience, National Chengchi University, Taipei, Taiwan 5Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan 6Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan 7Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan 8Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan 9Biophotonics and Molecular Imaging Research Center (BMIRC), National Yang-Ming University, Taipei, Taiwan 10Current address: Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong *These authors have contributed equally to this work Correspondence to: Te-Chang Lee, email: [email protected] Yi-Jang Lee, email: [email protected] Keywords: arsenic trioxide; sestrin 2; miR-182; oxidative stress; anti-oxidant effect Received: April 12, 2017 Accepted: February 24, 2018 Published: March 23, 2018 Copyright: Lin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. -
Mono-Uridylation of Pre-Microrna As a Key Step in the Biogenesis of Group II Let-7 Micrornas
Mono-Uridylation of Pre-MicroRNA as a Key Step in the Biogenesis of Group II let-7 MicroRNAs Inha Heo,1,2,3 Minju Ha,1,2,3 Jaechul Lim,1,2 Mi-Jeong Yoon,2 Jong-Eun Park,1,2 S. Chul Kwon,1,2 Hyeshik Chang,1,2 and V. Narry Kim1,2,* 1Institute for Basic Science 2School of Biological Sciences Seoul National University, Seoul 151-742, Korea 3These authors contributed equally to this work *Correspondence: [email protected] http://dx.doi.org/10.1016/j.cell.2012.09.022 SUMMARY hairpin (Denli et al., 2004; Gregory et al., 2004; Han et al., 2004, 2006; Landthaler et al., 2004). Like other RNase-III-type RNase III Drosha initiates microRNA (miRNA) matu- endonucleases, Drosha introduces a staggered cut such that ration by cleaving a primary miRNA transcript and the product acquires a characteristic 2 nt overhang at the 30 releasing a pre-miRNA with a 2 nt 30 overhang. Dicer terminus. After cleavage, the pre-miRNA is exported to the recognizes the 2 nt 30 overhang structure to selec- cytoplasm by exportin 5 in a complex with Ran-GTP (Bohnsack tively process pre-miRNAs. Here, we find that, unlike et al., 2004; Lund et al., 2004; Yi et al., 2003). The cytoplasmic prototypic pre-miRNAs (group I), group II pre- RNase III Dicer processes the pre-miRNA further to liberate a small RNA duplex (Bernstein et al., 2001; Grishok et al., miRNAs acquire a shorter (1 nt) 30 overhang from 0 2001; Hutva´ gner et al., 2001; Ketting et al., 2001; Knight and Drosha processing and therefore require a 3 -end Bass, 2001). -
A Novel PLEKHA7 Interactor at Adherens Junctions
Thesis PDZD11: a novel PLEKHA7 interactor at adherens junctions GUERRERA, Diego Abstract PLEKHA7 is a recently identified protein of the AJ that has been involved by genetic and genomic studies in the regulation of miRNA signaling and cardiac contractility, hypertension and glaucoma. However, the molecular mechanisms behind PLEKHA7 involvement in tissue physiology and pathology remain unknown. In my thesis I report novel results which uncover PLEKHA7 functions in epithelial and endothelial cells, through the identification of a novel molecular interactor of PLEKHA7, PDZD11, by yeast two-hybrid screening, mass spectrometry, co-immunoprecipitation and pulldown assays. I dissected the structural basis of their interaction, showing that the WW domain of PLEKHA7 binds to the N-terminal region of PDZD11; this interaction mediates the junctional recruitment of PDZD11, identifying PDZD11 as a novel AJ protein. I provided evidence that PDZD11 forms a complex with nectins at AJ, its PDZ domain binds to the PDZ-binding motif of nectins. PDZD11 stabilizes nectins promoting the early steps of junction assembly. Reference GUERRERA, Diego. PDZD11: a novel PLEKHA7 interactor at adherens junctions. Thèse de doctorat : Univ. Genève, 2016, no. Sc. 4962 URN : urn:nbn:ch:unige-877543 DOI : 10.13097/archive-ouverte/unige:87754 Available at: http://archive-ouverte.unige.ch/unige:87754 Disclaimer: layout of this document may differ from the published version. 1 / 1 UNIVERSITE DE GENÈVE FACULTE DES SCIENCES Section de Biologie Prof. Sandra Citi Département de Biologie Cellulaire PDZD11: a novel PLEKHA7 interactor at adherens junctions THÈSE Présentée à la Faculté des sciences de l’Université de Genève Pour obtenir le grade de Doctor ès science, mention Biologie par DIEGO GUERRERA de Benevento (Italie) Thèse N° 4962 GENÈVE Atelier d'impression Repromail 2016 1 Table of contents RÉSUMÉ .................................................................................................................. -
Rnai-Mediated Specific Gene Silencing As a Tool for the Discovery of New Drug Targets in Giardia Lamblia; Evaluation Using the NADH Oxidase Gene
G C A T T A C G G C A T genes Article RNAi-Mediated Specific Gene Silencing as a Tool for the Discovery of New Drug Targets in Giardia lamblia; Evaluation Using the NADH Oxidase Gene Jaime Marcial-Quino 1,2,*,†, Saúl Gómez-Manzo 2,† ID , Francisco Fierro 3 ID , Yadira Rufino-González 4, Daniel Ortega-Cuellar 5 ID , Edgar Sierra-Palacios 6, America Vanoye-Carlo 7, Abigail González-Valdez 8, Angélica Torres-Arroyo 2, Jesús Oria-Hernández 2 and Horacio Reyes-Vivas 2,* 1 CONACYT-Instituto Nacional de Pediatría, Secretaría de Salud, Ciudad de México 04530, Mexico 2 Laboratorio de Bioquímica Genética, Instituto Nacional de Pediatría, Secretaría de Salud, Ciudad de México 04530, Mexico; [email protected] (S.G.-M.); [email protected] (A.T.-A.); [email protected] (J.O.-H.) 3 Departamento de Biotecnología, Universidad Autónoma Metropolitana, Iztapalapa 09340, Mexico; [email protected] 4 Laboratorio de Parasitología Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, Ciudad de México 04530, Mexico; [email protected] 5 Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, Ciudad de México 04530, Mexico; [email protected] 6 Colegio de Ciencias y Humanidades, Plantel Casa Libertad, Universidad Autónoma de la Ciudad de México, Ciudad de México 09620, Mexico; [email protected] 7 Laboratorio de Neurociencias, Instituto Nacional de Pediatría, Secretaría de Salud, Ciudad de México 04530, Mexico; [email protected] 8 Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04530, Mexico; [email protected] * Correspondence: [email protected] (J.M.-Q.); [email protected] (H.R.-V.); Tel.: +52-55-1084-0900 (ext. -
Post-Transcriptional Control of Mirna Biogenesis
Downloaded from rnajournal.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Michlewski and Caceres Post-transcriptional control of miRNA biogenesis GRACJAN MICHLEWSKI1,2 and JAVIER F. CÁCERES3 1Division of Infection and Pathway Medicine, University of Edinburgh, The Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK; 2Zhejiang University-University of Edinburgh Institute, Zhejiang University, 718 East Haizhou Rd., Haining, Zhejiang 314400, P.R. China; 3MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK Corresponding authors: [email protected], [email protected] 1 Downloaded from rnajournal.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Michlewski and Caceres ABSTRACT MicroRNAs (miRNAs) are important regulators of gene expression that bind complementary target mRNAs and repress their expression. Precursor miRNA molecules undergo nuclear and cytoplasmic processing events, carried out by the endoribonucleases, DROSHA and DICER, respectively, to produce mature miRNAs that are loaded onto the RISC (RNA-induced silencing complex) to exert their biological function. Regulation of mature miRNA levels is critical in development, differentiation and disease, as demonstrated by multiple levels of control during their biogenesis cascade. Here, we will focus on post- transcriptional mechanisms and will discuss the impact of cis-acting sequences in precursor miRNAs, as well as trans-acting factors that bind to these precursors and influence their processing. In particular, we will highlight the role of general RNA-binding proteins (RBPs) as factors that control the processing of specific miRNAs, revealing a complex layer of regulation in miRNA production and function. -
RNA Binding Proteins in the Mirna Pathway
Review RNA Binding Proteins in the miRNA Pathway Patrick Connerty 1,†, Alireza Ahadi 2,† and Gyorgy Hutvagner 2,* Received: 9 November 2015; Accepted: 23 December 2015; Published: 26 December 2015 Academic Editor: Kotb Abdelmohsen 1 Faculty of Science 1, University of Technology, Sydney, NSW 2007, Australia; [email protected] 2 Faculty of Engineering and Information technology 2, University of Technology, Sydney, NSW 2007, Australia; [email protected] * Correspondence: [email protected]; Tel.: +61-2951-44827 † These authors contributed equally to this work. Abstract: microRNAs (miRNAs) are short ~22 nucleotides (nt) ribonucleic acids which post-transcriptionally regulate gene expression. miRNAs are key regulators of all cellular processes, and the correct expression of miRNAs in an organism is crucial for proper development and cellular function. As a result, the miRNA biogenesis pathway is highly regulated. In this review, we outline the basic steps of miRNA biogenesis and miRNA mediated gene regulation focusing on the role of RNA binding proteins (RBPs). We also describe multiple mechanisms that regulate the canonical miRNA pathway, which depends on a wide range of RBPs. Moreover, we hypothesise that the interaction between miRNA regulation and RBPs is potentially more widespread based on the analysis of available high-throughput datasets. Keywords: miRNA; RNA binding protein; Drosha; Dicer; Argonaute; cross-linking and immonoprecipitation (CLIP) 1. Introduction MicroRNAs (miRNAs) are an abundant class of small regulatory RNAs about 19–22 nucleotides (nt) in length [1]. They have been predicted to regulate the expression of more than 60% of mammalian genes and play fundamental roles in most biological processes including multiple diseases [2,3]. -
Regulation of Let-7 and Its Target Oncogenes (Review)
ONCOLOGY LETTERS 3: 955-960, 2012 Regulation of let-7 and its target oncogenes (Review) XIRUI WANG*, LEI CAO*, YINGYI WANG*, XIEFENG WANG, NING LIU and YONGPING YOU Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China Received October 20, 2011; Accepted February 1, 2012 DOI: 10.3892/ol.2012.609 Abstract. MicroRNAs (miRNAs) are highly evolutionarily- untranslated regions (3' UTRs) of target mRNA transcripts (1). conserved non-coding small RNAs, which were first identified miRNAs exist in three forms during their synthesis: primary in Caenorhabditis elegans. Let-7 miRNA is involved in the miRNAs (pri-miRNAs), precursor miRNAs (pre-miRNAs) and regulation of gene expression in cells. Several novel factors mature miRNAs. Pri-miRNA contains a 5' cap and poly(A) tail and feedback loops involved in the regulation of the synthesis and is first transcribed by RNA polymerase II as a long tran- of let-7 have been identified and additional let-7 target genes script. Following the processing of pri-miRNA by the RNase III have been found. Let-7 has also been shown to be significantly enzyme Drosha in the nucleus, pre-miRNA is released, exported correlated with the occurrence and development of cancer and to the cytoplasm by exportin-5 and processed by the RNase III the results of preliminary studies suggest that it is involved enzyme Dicer to produce a mature miRNA-miRNA duplex (2). in the regulation of oncogenic pathways in numerous types Single-stranded mature miRNA is incorporated from the duplex of tumors. Let-7 is, therefore, a potential molecular target into an RNA-induced silencing complex (RISC) where it medi- for tumor therapy. -
RNA Editing of Human Micrornas
Open Access Research2006BlowetVolume al. 7, Issue 4, Article R27 RNA editing of human microRNAs comment Matthew J Blow*, Russell J Grocock†, Stijn van Dongen†, Anton J Enright†, Ed Dicks*, P Andrew Futreal*, Richard Wooster* and Michael R Stratton*‡ Addresses: *Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. †Computational and Functional Genomics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. ‡Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK. Correspondence: Michael R Stratton. Email: [email protected] reviews Published: 4 April 2006 Received: 8 December 2005 Revised: 30 January 2006 Genome Biology 2006, 7:R27 (doi:10.1186/gb-2006-7-4-r27) Accepted: 6 March 2006 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2006/7/4/R27 © 2006 Blow et al.; licensee BioMed Central Ltd. reports This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Human<p>Atargets.</p> survey miRNA of RNAediting editing of miRNAs from ten human tissues indicates that RNA editing increases the diversity of miRNAs and their Abstract deposited research Background: MicroRNAs (miRNAs) are short RNAs of around 22 nucleotides that regulate gene expression. The primary transcripts of miRNAs contain double-stranded RNA and are therefore potential substrates for adenosine to inosine (A-to-I) RNA editing. -
Microprocessor Dynamics and Interactions at Endogenous Imprinted C19MC Microrna Genes
Research Article 2709 Microprocessor dynamics and interactions at endogenous imprinted C19MC microRNA genes Cle´ment Bellemer1,2, Marie-Line Bortolin-Cavaille´ 1,2, Ute Schmidt3, Stig Mølgaard Rask Jensen4,*, Jørgen Kjems4, Edouard Bertrand3 and Je´roˆ me Cavaille´ 1,2,` 1Laboratoire de Biologie Mole´culaire Eucaryote (LBME), Universite´ Paul Sabatier (UPS), Universite´ de Toulouse, 31000 Toulouse, France 2CNRS, LBME, 31000 Toulouse, France 3Institute of Molecular Genetics of Montpellier, CNRS UMR 5535, 34293 Montpellier, France 4Interdisciplinary Nanoscience Center iNANO, Department of Molecular Biology, Aarhus University, C.F. Møllers Alle´, Building 1130, Room 404, 8000 Aarhus, Denmark *Present address: National Cancer Institute, Frederick Building 567, Room 261/275, Frederick, MD 21702, USA `Author for correspondence ([email protected]) Accepted 2 February 2012 Journal of Cell Science 125, 2709–2720 ß 2012. Published by The Company of Biologists Ltd doi: 10.1242/jcs.100354 Summary Nuclear primary microRNA (pri-miRNA) processing catalyzed by the DGCR8–Drosha (Microprocessor) complex is highly regulated. Little is known, however, about how microRNA biogenesis is spatially organized within the mammalian nucleus. Here, we image for the first time, in living cells and at the level of a single microRNA cluster, the intranuclear distribution of untagged, endogenously-expressed pri-miRNAs generated at the human imprinted chromosome 19 microRNA cluster (C19MC), from the environment of transcription sites to single molecules of fully released DGCR8-bound pri-miRNAs dispersed throughout the nucleoplasm. We report that a large fraction of Microprocessor concentrates onto unspliced C19MC pri-miRNA deposited in close proximity to their genes. Our live-cell imaging studies provide direct visual evidence that DGCR8 and Drosha are targeted post-transcriptionally to C19MC pri-miRNAs as a preformed complex but dissociate separately. -
Interplay of RNA-Binding Proteins and Micrornas in Neurodegenerative Diseases
International Journal of Molecular Sciences Review Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases Chisato Kinoshita 1,* , Noriko Kubota 1,2 and Koji Aoyama 1,* 1 Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan; [email protected] 2 Teikyo University Support Center for Women Physicians and Researchers, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan * Correspondence: [email protected] (C.K.); [email protected] (K.A.); Tel.: +81-3-3964-3794 (C.K.); +81-3-3964-3793 (K.A.) Abstract: The number of patients with neurodegenerative diseases (NDs) is increasing, along with the growing number of older adults. This escalation threatens to create a medical and social crisis. NDs include a large spectrum of heterogeneous and multifactorial pathologies, such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and multiple system atrophy, and the formation of inclusion bodies resulting from protein misfolding and aggregation is a hallmark of these disorders. The proteinaceous components of the pathological inclusions include several RNA-binding proteins (RBPs), which play important roles in splicing, stability, transcription and translation. In addition, RBPs were shown to play a critical role in regulating miRNA biogenesis and metabolism. The dysfunction of both RBPs and miRNAs is Citation: Kinoshita, C.; Kubota, N.; often observed in several NDs. Thus, the data about the interplay among RBPs and miRNAs and Aoyama, K. Interplay of RNA-Binding Proteins and their cooperation in brain functions would be important to know for better understanding NDs and microRNAs in Neurodegenerative the development of effective therapeutics.